Shriram Revankar is VP at Dolby Laboratories, Inc. (DLB). They have made 3 open-market trades across 1 company since 2025, most recently 2026-08-14.
CIK 0001928994
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| DLB | 73,274 | $4.8M |
Shares reported on the most recent Form 4, priced at the 2026-08-18 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| DLB | SELL | 2026-08-14 | 2026-08-18 | $62.71 | $188K | -0.5% | -7.3% | — |
| DLB | SELL · 10b5-1 | 2026-05-15 | 2026-05-19 | $54.90 | $165K | +6.2% | -1.0% | +16.1% |
| DLB | SELL | 2026-02-17 | 2026-02-17 | $66.14 | $198K | +4.2% | -3.7% | -14.8% |
| DLB | SELL · 10b5-1 | 2025-11-21 | 2025-11-24 | $65.55 | $197K | +0.4% | -0.8% | -4.4% |
| DLB | SELL | 2025-08-22 | 2025-08-26 | $74.92 | $524K | +0.6% | -2.0% | -8.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.